参考文献/References:
[1] 刘毅龙,陈鹏宇,雷 江,等.SGLT-2抑制剂在2型糖尿病合并心血管疾病治疗中的应用研究进展[J].陕西医学杂志,2019,48(3):407-409.
[2] 李 靓,谢 巍,姜志胜,等.我国动脉粥样硬化基础研究近三年进展[J].中国动脉硬化杂志,2015,8(11):1182-1188.
[3] Orekhov AN.LDL and foam cell formation as the basis of atherogenesis[J].Current Opinion in Iipidology,2018,29(4):279-284.
[4] 戎 光,周庆兵,李 婧,等.化浊通脉方对ox-LDL诱导的RAW264.7来源泡沫细胞胆固醇逆转运相关基因表达作用研究[J].陕西中医,2019,40(12):1664-1668.
[5] Corrêa R,Silva L FF,Ribeiro DJS,et al.Lysophosphatidylcholine induces NLRP3 inflammasome-mediated foam cell formation and pyroptosis in human monocytes and endothelial cells[J].Frontiers in Immunology,2019(10):2927.
[6] Leitinger N,Schulman IG.Phenotypic polarization of macrophages in atherosclerosis[J].Arteriosclerosis Thrombosis and Vascular Biology, 2013,33(6):1120-1126.
[7] Komohara Y,Fujiwara Y,Ohnishi K,et al.Contribution of macrophage polarization to metabolic diseases[J].Journal of Atherosclerosis and Thrombosis, 2016,23(1):10-17.
[8] Dasilva RF,Lappalainen J,Lee-Rueckert M,et al.Conversion of human M-CSF macrophages into foam cells reduces their proinflammatory responses to classical M1-polarizing activation[J].Atherosclerosis, 2016,248(1):170-178.
[9] Stöger JL,Gijbels MJ,Van der VS,et al.Distribution of macrophage polarization markers in human atherosclerosis[J].Atherosclerosis,2012,225(2):461-468.
[10] Gistera A,Hansson GK.The immunology of atherosclerosis[J].Nature Reviews Nephrology.2017,13(6):368.
[11] Allahverdian S,Chehroudi AC,Mcmanus BM,et al.Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis[J].Circulation, 2014,129(15):1551-1559.
[12] Allahverdian S,Pannu PS,Francis GA.Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation[J].Cardiovascular Research,2012,95(2):165-172.
[13] Rivera J,Walduck AK,Thomas SR,et al.Accumulation of serum lipids by vascular smooth muscle cells involves a macropinocytosis-like uptake pathway and is associated with the downregulation of the ATP-binding cassette transporter A1[J].Naunyn-Schmiedeberg's Archives of Pharmacology,2013,386(12):1081-1093.
[14] Costales P,Fuentes-Prior P,Castellano J,et al.K domain CR9 of low density lipoprotein(LDL)receptor-related protein 1(LRP1)is critical for aggregated LDL-induced foam cell formation from human vascular smooth muscle cells[J].Journal of Biological Chemistry,2015,290(24):14852-14865.
[15] Vengrenyuk Y,Nishi H,Long X,et al.Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype[J].Arteriosclerosis Thrombosis and Vascular Biology,2015,35(3):535-546.
[16] Ben J,Zhu X,Zhang H,et al.Class A1 scavenger receptors in cardiovascular diseases[J].British Journal of Pharmacology, 2015,172(23):5523-5530.
[17] Nègre-Salvayre A,Augé N,Camaré C,et al.Dual signaling evoked by oxidized LDLs in vascular cells[J].Free Radical Biology and Medicine,2017,106(2):118-133.
[18] Tertov VV,Orekhov AN,Sobenin IA,et al.Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation[J].Circulation research, 1992,71(1):218-228.
[19] Corrêa R,Silva LFF,Ribeiro DJS,et al.Lysophosphatidylcholine induces NLRP3 inflammasome-mediated foam cell formation and pyroptosis in human monocytes and endothelial cells[J].Frontiers in Immunology,2019,10(1):2927.
[20] Torsney E,Xu Q.Resident vascular progenitor cells[J].Journal of Molecular and Cellular Cardiology,2011,50(2):304-311.
[21] Psaltis PJ,Simari RD.Vascular wall progenitor cells in health and disease[J].Circulation Research,2015,116(8):1392-1412.
[22] 吴彩霞,孙超峰.环氧合酶在动脉粥样硬化中研究进展[J].陕西医学杂志,2009,38(8):1075-1077,1105.
[23] Calvo MJ,Martínez MS,Torres W,et al.Omega-3 polyunsaturated fatty acids and cardiovascular health:a molecular view into structure and function[J].Vessel Plus,2017,1(3):116-128.
[24] Li Na,Zhang RX,Xie XJ,et al.Autophagy in chronic stress induced atherosclerosis[J].Clin Chim Acta,2020(503):70-75.
[25] Chistiakov DA,Bobryshev YV,Orekhov AN.Macrophage-mediated cholesterol handling in atherosclerosis[J].Journal of Cellular and Molecular Medicine, 2016,20(1):17-28.
[26] Makinen PI,Lappalainen JP,Heinonen SE,et al.Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors[J].Cardiovascular Research,2010,88(3):530-538.
[27] Hashizume M,Mihara M.Blockade of IL-6 and TNF-α inhibited oxLDL-induced production of MCP-1 via scavenger receptor induction[J].European Journal of Pharmacology,2012,689(1-3):249-254.
[28] Tarhda Z,Semlali O,Kettani A,et al.Three dimensional structure prediction of fatty acid binding site on human transmembrane receptor CD36[J].Bioinformatics and Biology Insights,2013(7):S12276.
[29] Mansor LS,Sousa Fialho MDL,Yea G,et al.Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia/reoxygenation[J].Cardiovascular Research,2017,113(7):737-748.
[30] Tang F,Cao Y,Wang T,et al.Tanshinone IIA attenuates atherosclerosis in ApoE/mice through down-regulation of scavenger receptor expression[J].European Journal of Pharmacology, 2011,650(1):275-284.
[31] Schaeffer DF,Riazy M,Parhar KS,et al.LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma[J].Journal of Lipid Research,2009,50(8):1676-1684.
[32] Yoshida H,Kondratenko N,Green S,et al.Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor[J].Biochemical Journal,1998,334(1):9-13.
[33] Mehta JL,Chen J,Hermonat PL,et al.Lectin-like,oxidized low-density lipoprotein receptor-1(LOX-1):a critical player in the development of atherosclerosis and related disorders[J].Cardiovascular Research,2006,69(1):36-45.
相似文献/References:
[1]刘玉珊.老年动脉粥样硬化性心肌梗死患者血清胱抑素C水平与血管内皮细胞损伤相关性研究*[J].陕西医学杂志,2020,49(4):431.
LIU Yushan..Relationship between serum cystatin C level and vascular endothelial cell injury in elderly patients with atherosclerotic myocardial infarction[J].,2020,49(10):431.
[2]刘兆宜,沈洲立,岳跃兵,等.类风湿关节炎并发动脉粥样硬化相关性研究进展*[J].陕西医学杂志,2020,49(11):1534.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.043]
LIU Zhaoyi,SHEN Zhouli,YUE Yuebing,et al.Research progress on the correlation between rheumatoid arthritis and atherosclerosis[J].,2020,49(10):1534.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.043]
[3]吴皓宇,曹怿玮,汪玲果,等.血管生成素-2促进内皮细胞基质金属蛋白酶-2表达实验研究[J].陕西医学杂志,2021,50(10):1183.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.002]
WU Haoyu,CAO Yiwei,WANG Lingguo,et al.Experimental study of angiopoietin-2 promoting the expression of matrix metalloproteinase-2 in endothelial cells[J].,2021,50(10):1183.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.002]
[4]谢继超,沈 冲,杨 松.血小板源性生长因子在心血管系统疾病中的作用研究进展[J].陕西医学杂志,2023,52(9):1279.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.039]
XIE Jichao,SHEN Chong,YANG Song.Research progress of platelet-derived growth factor in cardiovascular diseases[J].,2023,52(10):1279.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.039]
[5]孙黎明,夏晓露,马红萍.高尿酸血症与高血压及心血管疾病关系研究进展[J].陕西医学杂志,2024,(2):286.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.031]
[6]陈 静,王晓玲,安 康,等.内皮脂肪酶和脂蛋白酶在冠状动脉粥样硬化发生及发展中的作用研究进展[J].陕西医学杂志,2024,(6):862.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.030]
CHEN Jing,WANG Xiaoling,AN Kang,et al.Research progress on role of endothelial lipase and lipoproteinases in occurrence and development of coronary atherosclerosis[J].,2024,(10):862.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.030]